Sepsis 2012 andbeyond
description
Transcript of Sepsis 2012 andbeyond
SEPSIS
Dr Riyas A
MD Anaesthesia
SEPSIS Severe sepsis and septic shock are
major health care problems
DEFINITIONS Sepsis:presence of infection with
systemic manifestation of infection Severe sepsis;presence of sepsis with
evidence of sepsis induced organ dysfunction or tissue hypoperfusion
Septic shock:sepsis induced hypotension persisting despite fluid resucitation
MANAGEMENT A)initial resuscitation B)screening C)diagnosis D)antimicrobial therapy E)source control F)infective prevention G)fluid therapy H) Vasopressor I) Corticosteroid
MANAGEMENT J) supportive therapy a) blood products administration b) immunoglobulins c) selenium d) recombinant activated protein
c e) sedation,analgesia,NMB f) glucose control g)RRT
H)bicarbonate therapy i)DVT prophylaxis J)stress ulcer prophylaxis K)nutrtion support
RESUSCITATION GOALS IN FIRST 6 HOURS
Central venous pressure 8 to 12 mm Hg (grade 1C)
Mean arterial pressure (MAP) ≥65 mm Hg (grade 1C)
Urine output ≥0.5 mL/kg/hour (grade 1C)
Superior vena cava oxygenation saturation (Scvo2) 70%
mixed venous oxygen saturation (Svo2) 65%
DIAGNOSTIC CRITERIA
THINGS TO BE COMPLETE IN FIRST 6 HRS
FIRST 3 HR
Obtain blood culture Measure lactate level Broad spectrum antibiotis 30ml/kg fluid for hypoension or lactate
level
WITH IN 6HR Vasopressors Remeasure lactate level
FLUIDS
Crystalloids as first choice for initial fluid resuscitation (grade 1B)
Initial minimum crystalloid challenge of 30 mL/kg (grade 1C)
DIAGNOSIS 10 ml of blood From two site percutaneous and insitu
catheter Other culture samples
ANTIMICROBIALS
within 1 hour of recognition of septic shock (grade 1B) and severe sepsis without septic shock (grade 1C)
Broad spectrum 7-10 days Recently used one should be avoided Combination therapy
INFECTION PREVENTION Selective oral as well as digestive
decontamination Others include hand hygeine nursing care elevated head end of the table Sub glottic suctioning
VASOPRESSORS AND INOTROPES
Norepinephrine as first choice NE+Epn Vasopressin 0.03u/min Phenylephrine not recommended
Dobutamine infusion trial up to 20 µg/kg/minute administered or added to vasopressor in the case of myocardial dysfunction or ongoing signs of hypoperfusion
CORTICOSTEROIDS
No corticosteroids in the absence of refractory shock (grade 1D)
Supportive therapy for sever sepsis
BLOOD PRODUCTS
PRBC transfusion when Hb ≤ 7gm% target hemoglobin concentration of 7.0–
9.0 g/dL in adults (grade 1B)
IMMUNOGLOBULINS No role
SELENIUM & PROTEIN C No role
MECHANICAL VENTILATION ARDS protocol
SEDATION ANALGESIA AND NMB CONTINOUS OR INTERMITTENT
SEDATION CONTINOUS OR INTERMITTENT UNDER
TRAIN OF FOUR MONITORING
GLUCOSE CONTROL ≤180 MG% To be monitored every 1 or 2 hr
OTHER RRT Stress ulcer prophlyalxis Dvt prophylaxis Nutrition support
THANK YOU